Lixte Biotechnology Holdings Inc
NASDAQ:LIXT
Lixte Biotechnology Holdings Inc
NASDAQ:LIXT
Price:
3.05
USD
5.17%
Market Closed
Market Cap:
$19.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lixte Biotechnology Holdings Inc
NASDAQ:LIXT
|
US |
|
Soiken Holdings Inc
TSE:2385
|
JP |
|
V
|
Vista Land & Lifescapes Inc
XPHS:VLL
|
PH |
|
Jyothy Labs Ltd
NSE:JYOTHYLAB
|
IN |
|
Black Spruce Exploration Inc
XTSX:BARK
|
CA |
|
Ework Group AB
STO:EWRK
|
SE |
|
J
|
Jetema Co Ltd
KOSDAQ:216080
|
KR |
|
A
|
Answer Technology Co Ltd
TWSE:3528
|
TW |
|
Marcus & Millichap Inc
NYSE:MMI
|
US |
|
B
|
Bikeexchange Ltd
ASX:BEX
|
AU |
|
D
|
Dynapac Co Ltd
TSE:3947
|
JP |
|
Seagate Technology Holdings PLC
NASDAQ:STX
|
IE |
|
Ituran Location and Control Ltd
NASDAQ:ITRN
|
IL |
|
A
|
AREIT, Inc
XPHS:AREIT
|
PH |
|
Decision Diagnostics Corp
OTC:DECN
|
US |
|
Katapult Holdings Inc
NASDAQ:KPLT
|
US |
Balance Sheet
Balance Sheet Decomposition
Lixte Biotechnology Holdings Inc
Lixte Biotechnology Holdings Inc
Balance Sheet Decomposition is not available for
Lixte Biotechnology Holdings Inc
Lixte Biotechnology Holdings Inc
Balance Sheet
Lixte Biotechnology Holdings Inc
Lixte Biotechnology Holdings Inc
Currency: USD
| Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
1
|
1
|
0
|
2
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
1
|
4
|
3
|
5
|
5
|
5
|
4
|
1
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
2
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
1
|
4
|
3
|
5
|
5
|
5
|
4
|
1
|
0
|
|
| Cash Equivalents |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
1
|
1
|
0
|
2
|
2
|
0
|
2
|
1
|
1
|
1
|
0
|
1
|
4
|
3
|
5
|
5
|
6
|
4
|
1
|
5
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
1
N/A
|
1
-16%
|
0
-92%
|
2
+3 100%
|
2
+21%
|
0
-78%
|
2
+307%
|
1
-68%
|
1
-4%
|
1
+11%
|
0
-28%
|
1
+219%
|
4
+217%
|
3
-38%
|
5
+96%
|
5
-3%
|
6
+9%
|
4
-23%
|
1
-73%
|
13
+1 012%
|
|
| Liabilities | ||||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+1 900%
|
0
+25%
|
0
+52%
|
0
-21%
|
0
-33%
|
0
+75%
|
0
-26%
|
0
+23%
|
0
-16%
|
0
+7%
|
0
-24%
|
0
+68%
|
0
-43%
|
0
+14%
|
0
-8%
|
0
+36%
|
0
+30%
|
0
-20%
|
0
+1%
|
3
+864%
|
|
| Equity | ||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
2
|
|
| Retained Earnings |
0
|
1
|
2
|
4
|
5
|
6
|
8
|
12
|
13
|
16
|
19
|
21
|
23
|
25
|
27
|
30
|
37
|
43
|
48
|
52
|
58
|
|
| Additional Paid In Capital |
0
|
1
|
3
|
3
|
5
|
8
|
8
|
13
|
13
|
16
|
17
|
17
|
20
|
25
|
26
|
32
|
38
|
45
|
49
|
49
|
66
|
|
| Other Equity |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
1
N/A
|
0
-31%
|
0
N/A
|
1
N/A
|
2
+34%
|
0
-95%
|
1
+1 763%
|
0
-84%
|
0
+13%
|
0
+15%
|
0
-32%
|
1
+376%
|
4
+313%
|
2
-41%
|
5
+106%
|
5
-4%
|
5
+8%
|
4
-23%
|
1
-79%
|
10
+1 068%
|
|
| Total Liabilities & Equity |
0
N/A
|
1
N/A
|
1
-16%
|
0
-92%
|
2
+3 100%
|
2
+21%
|
0
-78%
|
2
+307%
|
1
-68%
|
1
-4%
|
1
+11%
|
0
-28%
|
1
+219%
|
4
+217%
|
3
-38%
|
5
+96%
|
5
-3%
|
6
+9%
|
4
-23%
|
1
-73%
|
13
+1 012%
|
|
| Shares Outstanding | ||||||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
9
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
|
Switch to:
Switch to:
See Also
Discover More
